Skip to content
value.today

Maculogix, Inc.

🇺🇸 Atlanta, Georgia, USAHealth CareFounded 2008

Formerly Apeliotus Vision Science, Inc.

Total raised
$105 M
7 rounds on record
Latest round
$22 M
Dec 2020
First round on record
Jul 2012
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Maculogix, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$22 MNo. 7$10 to $50 million

Maculogix, Inc.: Raise no. 7, Dec 2020

Investors in this round

3 investors had bought by the notice of Dec 14, 2021: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel L. Dorsey · Executive Officer
  • David L. Miller · Executive Officer
  • Gary L. VanMatre · Executive Officer
  • Gregory R. Jackson · Executive Officer, Director
  • Jennifer L. DelPrete · Executive Officer
  • William D. McPhee · Executive Officer, Director
  • Carole L. Nuechterlein · Director
  • Jack L. Nielsen · Director
  • Nathan L. Dau · Director
  • Ronald P. Thiboutot · Director
  • Stephen L. Rose · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William D. McPhee, President and CEO. Source: SEC Form D and 2 amendments, newest notice filed Dec 14, 2021. Read the notice at the SEC.

debt, optionsSEC
Feb 2020$16 MNo. 6$10 to $50 million

Maculogix, Inc.: Raise no. 6, Feb 2020

Investors in this round

8 investors had bought by the notice of Nov 12, 2020: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $17 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$170,905
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan D. Dorsey · Executive Officer
  • David P. Miller · Executive Officer
  • Gary P. VanMatre · Executive Officer
  • Gregory D. Jackson · Executive Officer, Director
  • William D. McPhee · Executive Officer, Director
  • Carole P. Nuechterlein · Director
  • Jack P. Nielsen · Director
  • Nathan P. Dau · Director
  • Ronald P. Thiboutot · Director
  • Stephen L. Rose · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • New Harbor Venture Partners LLC (CRD 283996) · Spring Lake, New JerseySold in CA, CT, GA, IL, MA, MD, MN, NC, NJ, NY, PA, TN, VT

Signed by William D. McPhee, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 12, 2020. Read the notice at the SEC.

equity, optionsSEC
Mar 2019$38 MNo. 5$10 to $50 million

Maculogix, Inc.: Raise no. 5, Mar 2019

Investors in this round

12 investors had bought by the notice of Mar 13, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $43 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$900,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Armond P. Dantino · Executive Officer
  • David P. Miller · Executive Officer
  • Dennis J. Siegel · Executive Officer
  • Gregory R. Jackson · Executive Officer, Director
  • Harold P. Mapes · Executive Officer
  • Robin P. Mattson · Executive Officer
  • William D. McPhee · Executive Officer, Director
  • Carole P. Nuechterlein · Director
  • Jack P. Nielsen · Director
  • Nathan P. Dau · Director
  • Ronald P. Thiboutot · Director
  • Stephen L. Rose · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • New Harbor Venture Partners LLC (CRD 283996) · Spring Lake, New JerseySold in CA, CT, GA, IL, MA, MD, MN, NC, NJ, NY, PA, TN, VT

Remarks in the notice

  • On fees: “Warrants to purchase 375,586 shares of Common Stock.”

Signed by William D. McPhee, President and CEO. Source: SEC Form D, newest notice filed Mar 13, 2019. Read the notice at the SEC.

equity, optionsSEC
Dec 2016$18 MNo. 4$10 to $50 million

Maculogix, Inc.: Raise no. 4, Dec 2016

Investors in this round

7 investors had bought by the notice of Dec 31, 2018: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis Siegel · Executive Officer
  • William McPhee · Executive Officer, Director
  • Gregory R. Jackson · Director
  • Ronald P. Thiboutot · Director
  • Stephen R. Rose · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “William McPhee and Dennis Siegel will continue to receive their annual salary.”

Signed by William McPhee, Ceo. Source: SEC Form D and 3 amendments, newest notice filed Dec 31, 2018. Read the notice at the SEC.

debt, optionsSEC
Jul 2015$5 MNo. 3$2 to $10 million

Maculogix, Inc.: Raise no. 3, Jul 2015

Investors in this round

4 investors had bought by the notice of Jul 31, 2015: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John G. Edwards · Executive Officer, Director
  • Gregory R. Jackson · Director
  • Ronald P. Thiboutot · Director
  • Stephen L. Rose · Director
  • William D. McPhee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John G. Edwards, President. Source: SEC Form D, newest notice filed Jul 31, 2015. Read the notice at the SEC.

equitySEC
Jun 2014$4 MNo. 2$2 to $10 million

Maculogix, Inc.: Raise no. 2, Jun 2014

Investors in this round

7 investors had bought by the notice of Jul 31, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $7 M offered; $4 M still to sell
Smallest investment taken
$2,363
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John G. Edwards · Executive Officer, Director
  • Gregory R. Jackson · Director
  • Ronald P. Thiboutot · Director
  • William D. McPhee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John G. Edwards, President. Source: SEC Form D and 1 amendment, newest notice filed Jul 31, 2015. Read the notice at the SEC.

equitySEC
Jul 2012$3 MNo. 1$2 to $10 million

Maculogix, Inc.: Raise no. 1, Jul 2012

Investors in this round

6 investors had bought by the notice of Jul 25, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Edwards · Executive Officer, Director
  • Edward Newill · Director
  • Gregory Jackson · Director
  • Ronald Thiboutot · Director
  • Thomas Glover · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Edwards, President. Source: SEC Form D, newest notice filed Jul 25, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Maculogix, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2021).

    SEC Form D · Dec 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2021

That is all the official record says: Maculogix, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Maculogix, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Maculogix, Inc.
NameRoleNamed in
Daniel L. DorseyExecutive officerDec 2021
David L. MillerExecutive officerDec 2021
Gary L. VanMatreExecutive officerDec 2021
Gregory R. JacksonExecutive officerDec 2021
Jennifer L. DelPreteExecutive officerDec 2021
William D. McPheeExecutive officerDec 2021
Dan D. DorseyExecutive officerNov 2020
David P. MillerExecutive officerNov 2020
Gary P. VanMatreExecutive officerNov 2020
Gregory D. JacksonExecutive officerNov 2020
Armond P. DantinoExecutive officerAug 2020
Robin P. MattsonExecutive officerFeb 2020
Dennis J. SiegelExecutive officerMar 2019
Harold P. MapesExecutive officerMar 2019
Dennis SiegelExecutive officerDec 2018
William McPheeExecutive officerDec 2018
John G. EdwardsExecutive officerJul 2015
John EdwardsExecutive officerJul 2012
Carole L. NuechterleinDirectorDec 2021
Gregory R. JacksonDirectorDec 2021
Jack L. NielsenDirectorDec 2021
Nathan L. DauDirectorDec 2021
Ronald P. ThiboutotDirectorDec 2021
Stephen L. RoseDirectorDec 2021
William D. McPheeDirectorDec 2021
Carole P. NuechterleinDirectorNov 2020
Gregory D. JacksonDirectorNov 2020
Jack P. NielsenDirectorNov 2020
Nathan P. DauDirectorNov 2020
Stephen R. RoseDirectorDec 2018
William McPheeDirectorDec 2018
John G. EdwardsDirectorJul 2015
Edward NewillDirectorJul 2012
Gregory JacksonDirectorJul 2012
John EdwardsDirectorJul 2012
Ronald ThiboutotDirectorJul 2012
Thomas GloverDirectorJul 2012